Malignant melanoma is the fastest-growing and 7th most ... Melanomas thicker than 1 mm may require up to four annual visits during the first 2 years, followed by biannual and annual exams.
Learn how melanoma impacts African Americans, highlighting detection challenges, survival disparities, and prevention ...
As part of The Wistar Institute's Melanoma Research Center, the Villanueva lab pursues new ways to overcome the challenge of melanoma drug resistance. In this paper, the group took aim at melanomas ...
A 38-year-old British woman has been battling aggressive Stage 4 terminal melanoma—skin cancer—for the past eight years, ...
The lab of The Wistar Institute's Jessie Villanueva, Ph.D., has identified a new strategy for attacking treatment-resistant ...
Ph.D. candidate in Georgetown University’s tumor biology program defended his dissertation, titled “Molecular Signatures of ...
Despite advances in treatments and improvements in survival overall, many oncologists remain hesitant to tell patients ...
News Medical on MSN1d
Inhibiting S6K2 gene offers potential treatment for drug-resistant melanomaThe lab of The Wistar Institute's Jessie Villanueva, Ph.D., has identified a new strategy for attacking treatment-resistant melanoma: inhibiting the gene S6K2. .
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback